Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent.

Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent.

[This corrects the article DOI: 10.1371/journal.pone.0164785.].

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5231920?pdf=render

Similar Items

A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
by: Kenji Sugawara, et al.
Published: (2016-01-01)

Assessment of the effects of insulin secretagogues in humans.
by: Wallace, T, et al.
Published: (2000)

Author Correction: Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
by: Miao-Miao Zhao, et al.
Published: (2021-10-01)

Correction: Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: novel anti-nicotine vaccine using a trimeric coiled-coil hapten carrier.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: a novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells.
by: PLOS ONE Staff
Published: (2015-01-01)

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
by: Miao-Miao Zhao, et al.
Published: (2021-09-01)

Correction: Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling.
by: PLOS ONE Staff
Published: (2015-01-01)

Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism
by: Jessica R. Gooding, et al.
Published: (2015-10-01)

Correction: Drosophila tribbles antagonizes insulin signaling-mediated growth and metabolism via interactions with Akt kinase.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Transforming growth factor β and insulin signal changes in stromal fibroblasts of individual keratoconus patients.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population-Brazilian Metabolic Syndrome Study (BRAMS).
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.
by: PLOS ONE Staff
Published: (2015-01-01)

Phytochemical Investigation of <i>Lepionurus sylvestris</i> Blume and Their Anti-Diabetes Effects via Anti-Alpha Glucosidase and Insulin Secretagogue Activities Plus Molecular Docking
by: Sathianpong Phoopha, et al.
Published: (2023-08-01)

Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
by: Zachary A.P. Wintrob, et al.
Published: (2017-02-01)

Correction: Diagnostic criteria for depression in type 2 diabetes: a data-driven approach.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: novel biogenic aggregation of moss gemmae on a disappearing African glacier.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: A novel technique of serial biopsy in mouse brain tumour models.
by: PLOS ONE Staff
Published: (2019-01-01)

Correction: transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutatmatergic- and insulin-mediated neuronal processes.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Chronic exercise increases plasma brain-derived neurotrophic factor levels, pancreatic islet size, and insulin tolerance in a TrkB-dependent manner.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Sexual attraction modulates interpersonal distance and approach-avoidance movements towards virtual agents in males.
by: PLOS ONE Staff
Published: (2020-01-01)

Correction: Preserved endothelial function in young adults with type 1 diabetes.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
by: PLOS ONE Staff
Published: (2019-01-01)

Correction: Unravelling the Structural and Molecular Basis Responsible for the Anti-Biofilm Activity of Zosteric Acid.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: a novel missense mutation in ADAMTS10 in Norwegian Elkhound primary glaucoma.
by: PLOS ONE Staff
Published: (2015-01-01)

The growth hormone secretagogue receptor.
by: Korbonits, M, et al.
Published: (1999)

Correction: A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: CRISPR Content Correlates with the Pathogenic Potential of Escherichia coli.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Quantitative in vivo mapping of myocardial mitochondrial membrane potential.
by: PLOS ONE Staff
Published: (2018-01-01)

Correction: effects of the magnetic resonance imaging contrast agent Gd-DTPA on plant growth and root imaging in rice.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials.
by: PLOS ONE Staff
Published: (2014-01-01)

Correction: Serum resistin and glomerular filtration rate in patients with type 2 diabetes.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Divalent cations are dispensable for binding to DNA of a novel positively charged olivomycin A derivative.
by: PLOS One Staff
Published: (2018-01-01)

Correction: A Novel Three-Filament Model of Force Generation in Eccentric Contraction of Skeletal Muscles.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
by: PLOS ONE Staff
Published: (2019-01-01)

Correction: Relationship between diabetes self-care practices and control of periodontal disease among type2 diabetes patients in Bangladesh.
by: PLOS ONE Staff
Published: (2021-01-01)